BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9496902)

  • 1. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line.
    Bae VL; Jackson-Cook CK; Maygarden SJ; Plymate SR; Chen J; Ware JL
    Prostate; 1998 Mar; 34(4):275-82. PubMed ID: 9496902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15.
    Jackson-Cook C; Bae V; Edelman W; Brothman A; Ware J
    Cancer Genet Cytogenet; 1996 Mar; 87(1):14-23. PubMed ID: 8646734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: association with decreased epidermal growth factor receptor (EGFR) expression.
    Bae VL; Jackson-Cook CK; Brothman AR; Maygarden SJ; Ware JL
    Int J Cancer; 1994 Sep; 58(5):721-9. PubMed ID: 8077059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.
    Wu HC; Hsieh JT; Gleave ME; Brown NM; Pathak S; Chung LW
    Int J Cancer; 1994 May; 57(3):406-12. PubMed ID: 8169003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
    Thalmann GN; Sikes RA; Wu TT; Degeorges A; Chang SM; Ozen M; Pathak S; Chung LW
    Prostate; 2000 Jul; 44(2):91-103 Jul 1;44(2). PubMed ID: 10881018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line.
    Webber MM; Bello D; Kleinman HK; Wartinger DD; Williams DE; Rhim JS
    Carcinogenesis; 1996 Aug; 17(8):1641-6. PubMed ID: 8761420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen.
    Plymate SR; Tennant M; Birnbaum RS; Thrasher JB; Chatta G; Ware JL
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3709-16. PubMed ID: 8855827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell-mediated restoration of chromosome 19.
    Astbury C; Jackson-Cook CK; Culp SH; Paisley TE; Ware JL
    Genes Chromosomes Cancer; 2001 Jun; 31(2):143-55. PubMed ID: 11319802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis.
    Plymate SS; Bae VL; Maddison L; Quinn LS; Ware JL
    Endocrine; 1997 Aug; 7(1):119-24. PubMed ID: 9449047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1.
    Hayward SW; Dahiya R; Cunha GR; Bartek J; Deshpande N; Narayan P
    In Vitro Cell Dev Biol Anim; 1995 Jan; 31(1):14-24. PubMed ID: 7535634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype.
    Hukku B; Mally M; Cher ML; Peehl DM; Kung H; Rhim JS
    Cancer Genet Cytogenet; 2000 Jul; 120(2):117-26. PubMed ID: 10942801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
    Hyytinen ER; Thalmann GN; Zhau HE; Karhu R; Kallioniemi OP; Chung LW; Visakorpi T
    Br J Cancer; 1997; 75(2):190-5. PubMed ID: 9010025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
    Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
    Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization of immortalized normal and primary tumor-derived human prostate epithelial cell cultures.
    Schwab TS; Stewart T; Lehr J; Pienta KJ; Rhim JS; Macoska JA
    Prostate; 2000 Jul; 44(2):164-71. PubMed ID: 10881026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human buccal epithelial cells transfected with the simian virus 40 T-antigen gene.
    Kulkarni PS; Sundqvist K; Betsholtz C; Höglund P; Wiman KG; Zhivotovsky B; Bertolero F; Liu Y; Grafström RC
    Carcinogenesis; 1995 Oct; 16(10):2515-21. PubMed ID: 7586160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reexpression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells.
    Plymate SR; Bae VL; Maddison L; Quinn LS; Ware JL
    Endocrinology; 1997 Apr; 138(4):1728-35. PubMed ID: 9075737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen.
    Nitta M; Katabuchi H; Ohtake H; Tashiro H; Yamaizumi M; Okamura H
    Gynecol Oncol; 2001 Apr; 81(1):10-7. PubMed ID: 11277643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line.
    Degeorges A; Hoffschir F; Cussenot O; Gauville C; Le Duc A; Dutrillaux B; Calvo F
    Int J Cancer; 1995 Sep; 62(6):724-31. PubMed ID: 7558421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel tumorigenic human prostate epithelial cell line (M2205): molecular cytogenetic characterization demonstrates C-MYC amplification and jumping translocations.
    Jackson-Cook C; Zou Y; Turner K; Astbury C; Ware J
    Cancer Genet Cytogenet; 2003 Feb; 141(1):56-64. PubMed ID: 12581899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vimentin or beta1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo.
    Zhang X; Fournier MV; Ware JL; Bissell MJ; Yacoub A; Zehner ZE
    Mol Cancer Ther; 2009 Mar; 8(3):499-508. PubMed ID: 19276168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.